OPPM
Opus Point Partners Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $280K | Hold |
2,112
| – | – | 0.51% | 42 |
|
|
2019
Q2 | $300K | Hold |
2,112
| – | – | 0.44% | 52 |
|
|
2019
Q1 | $307K | Sell |
2,112
-553
| -21% | -$80.4K | 0.42% | 59 |
|
|
2018
Q4 | $302K | Sell |
2,665
-161
| -6% | -$18.2K | 0.66% | 26 |
|
|
2018
Q3 | $380K | Buy |
2,826
+92
| +3% | +$12.4K | 0.91% | 36 |
|
|
2018
Q2 | $307K | Buy |
2,734
+121
| +5% | +$13.6K | 0.67% | 34 |
|
|
2018
Q1 | $279K | Buy |
2,613
+459
| +21% | +$49K | 0.55% | 40 |
|
|
2017
Q4 | $236K | Sell |
2,154
-2,801
| -57% | -$307K | 0.2% | 49 |
|
|
2017
Q3 | $535K | Buy |
4,955
+2,393
| +93% | +$258K | 0.48% | 42 |
|
|
2017
Q2 | $259K | Sell |
2,562
-1,879
| -42% | -$190K | 0.24% | 48 |
|
|
2017
Q1 | $399K | Buy |
4,441
+1,138
| +34% | +$102K | 0.3% | 45 |
|
|
2016
Q4 | $252K | Buy |
+3,303
| New | +$252K | 0.2% | 45 |
|